What is Nektar Therapeutics's inventories?

Nektar Therapeutics (NKTR) reported inventories of -$0 in Q4 2025.

What is the long-term trend for Nektar Therapeutics's inventories?

Over 5 years (2020 to 2025), Nektar Therapeutics's inventories has grown at a -100.0% compound annual growth rate (CAGR), from $15.29M to -$0.

What does inventories mean?

Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.

Nektar Therapeutics NKTR Inventories

Discontinued — last reported Q4 '25

Inventories at other companies

AmgenAMGN

$6.19B-8.1%

Regeneron PharmaceuticalsREGN

$3.1B-2.8%

ImmunityBio, Inc.IBRX

$18.86M+123%

Iovance Biotherapeutics, Inc.IOVA

$58.38M-10.9%

IncyteINCY

$331.42M-9.3%

Johnson & JohnsonJNJ

$14.58B+15.2%

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.19B+1,531%

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Nektar Therapeutics’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's inventories?: Nektar Therapeutics (NKTR) reported inventories of -$0 in Q4 2025.
What is the long-term trend for Nektar Therapeutics's inventories?: Over 5 years (2020 to 2025), Nektar Therapeutics's inventories has grown at a -100.0% compound annual growth rate (CAGR), from $15.29M to -$0.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.